US 10392432
Human antibodies to influenza hemagglutinin
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10392432 (Human antibodies to influenza hemagglutinin) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K2300/00